"你的发作告诉你什么? ":用于功能性的治疗工具
Lana Higson1, Terence J O'Brien1, Genevieve Rayner2
1Department of Neuroscience, The School of Translational Medicine, Monash University, Melbourne, Victoria, Australia; Department of Neurology, Alfred Hospital, Melbourne, Victoria, Australia.
Epilepsy & behavior : E&B
|July 26, 2024
概括
功能性发作的人通常将其视为强制性休息,个人成长或蔑视. 了解这些疾病表征可以改善患者与临床医生的沟通和治疗参与,以获得更好的健康结果.
科学领域:
- 神经学 神经学
- 精神病学是一个精神病学.
- 健康心理学 心理健康心理学
背景情况:
- 了解疾病表征对于改善健康结果至关重要.
- 关于功能性发作患者如何感知症状的心理功能,目前的研究有限.
研究的目的:
- 探索患者对其功能性发作的可能功能的概念化.
- 调查这些概念化如何与诊断接受和对心理病因学的开放性有关.
主要方法:
- 对99名被诊断患有功能性发作的参与者进行了半结构面试.
- 用定性主题内容分析和模式分析来分析对以下问题的反应:"你认为你的功能性症状告诉你什么?"
主要成果:
- 88%的参与者很容易解释他们的发作.
- 确定的主要主题是"强制性休息" (停止,放慢,放松),其次是"个人成长" (自我照顾,自我发展,接受) 和"蔑视".
- 拒绝诊断或心理基础的个人经常表达蔑视或回答"不知道".
结论:
- 患者对功能性发作的解释为非急性环境中的病情提供了宝贵的见解.
- 确定的主题可以为治疗讨论和以患者为中心的沟通策略提供信息.
- 这些发现可能会加强临床医生与患者的关系,治疗参与,以及针对功能性发作的干预目标.
相关概念视频
Antiepileptic Drugs: GABAergic Pathway Potentiators
363
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
363
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
279
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
279
Antiepileptic Drugs: Sodium Channel Blockers
475
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
475
Antiepileptic Drugs: Glutamate Antagonists
305
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
305
Antiepileptic Drugs: Calcium Channel Blockers
353
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
353
Arteries of the Lower Limbs
182
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
182


